Physician profile
Tian Xia
NPI 1467492728
$22,937.20
in general payments reported to CMS, 2019-2025
37 companies · $4,825 in 2025
The $4,825 reported for 2025 was more than what 93% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,572 · 2020: $3,820 · 2021: $5,084 · 2022: $4,000 · 2023: $739 · 2024: $1,897 · 2025: $4,825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,479 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,970 · Travel and Lodging: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,478.88 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,970.00 |
| Travel and Lodging | $1,012.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinefrontier, INC. | $7,666.91 | 2020-2025 | Inspan, Sijfuse, Nanofuse |
| Abbott Laboratories | $7,117.82 | 2019-2025 | Proclaim, Eterna |
| Medtronic, INC. | $2,765.08 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Vertiflex, INC. | $1,576.02 | 2019 | |
| Curonix LLC | $472.37 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Organogenesis INC. | $459.50 | 2023-2025 | Cygnus Dual, Apligraf, Puraply |
| Collegium Pharmaceutical, INC. | $351.28 | 2019-2021 | |
| Nevro Corp. | $272.92 | 2019-2020 | |
| Mml US, INC. | $267.39 | 2024 | Reactiv8 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $231.07 | 2019-2021 | |
| Boston Scientific Corporation | $176.15 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $150.16 | 2022-2024 | Ubrelvy, Qulipta |
| Axonics, INC. | $145.70 | 2024 | Axonics |
| Allergan, INC. | $127.96 | 2020-2021 | |
| Averitas Pharma INC. | $124.04 | 2024 | Qutenza |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $122.53 | 2020 | |
| Biodelivery Sciences International, INC. | $118.45 | 2019-2021 | |
| Spr Therapeutics, INC | $96.89 | 2019 | |
| Avanos Medical | $91.60 | 2022-2023 | Genvisc 850 Sodium Hyaluronate |
| Redhill Biopharma INC. | $64.35 | 2020-2021 | |
| Zavation Medical Products, LLC | $62.73 | 2025 | |
| Depuy Synthes Sales INC. | $51.83 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $47.34 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $39.45 | 2021 | |
| Amgen INC. | $38.36 | 2019-2021 | |
| Orthogenrx INC. | $36.97 | 2020-2021 | |
| Ascensia Diabetes Care US INC. | $35.92 | 2024-2025 | |
| Clariance, INC. | $34.85 | 2024 | |
| Tersera Therapeutics LLC | $34.36 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $27.01 | 2023 | Seglentis |
| Si-Bone, INC. | $25.18 | 2021 | |
| Novartis Pharmaceuticals Corporation | $22.97 | 2021 | |
| Medtronic USA, INC. | $21.09 | 2019 | |
| Sentynl Therapeutics, INC. | $16.66 | 2019 | |
| Shionogi INC | $15.92 | 2019 | |
| Fidia Pharma USA INC. | $15.18 | 2019 | |
| Nalu Medical, INC. | $13.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tian Xia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.